vs
Side-by-side financial comparison of Getty Images Holdings, Inc. (GETY) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($346.4M vs $282.3M, roughly 1.2× Getty Images Holdings, Inc.). HAEMONETICS CORP runs the higher net margin — 28.1% vs -32.2%, a 60.3% gap on every dollar of revenue. On growth, Getty Images Holdings, Inc. posted the faster year-over-year revenue change (14.1% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $7.7M). Over the past eight quarters, Getty Images Holdings, Inc.'s revenue compounded faster (12.7% CAGR vs 1.5%).
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
GETY vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $282.3M | $346.4M |
| Net Profit | $-90.9M | $97.3M |
| Gross Margin | 74.8% | 57.2% |
| Operating Margin | -8.5% | 36.1% |
| Net Margin | -32.2% | 28.1% |
| Revenue YoY | 14.1% | 4.8% |
| Net Profit YoY | -467.6% | — |
| EPS (diluted) | $-0.22 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $346.4M | ||
| Q4 25 | $282.3M | $339.0M | ||
| Q3 25 | $240.0M | $327.3M | ||
| Q2 25 | $234.9M | $321.4M | ||
| Q1 25 | $224.1M | $330.6M | ||
| Q4 24 | $247.3M | $348.5M | ||
| Q3 24 | $240.5M | $345.5M | ||
| Q2 24 | $229.1M | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | $-90.9M | $44.7M | ||
| Q3 25 | $21.6M | $38.7M | ||
| Q2 25 | $-34.4M | $34.0M | ||
| Q1 25 | $-102.6M | $58.0M | ||
| Q4 24 | $24.7M | $37.5M | ||
| Q3 24 | $-2.5M | $33.8M | ||
| Q2 24 | $3.7M | $38.4M |
| Q1 26 | — | 57.2% | ||
| Q4 25 | 74.8% | 59.7% | ||
| Q3 25 | 73.2% | 59.5% | ||
| Q2 25 | 72.1% | 59.8% | ||
| Q1 25 | 73.1% | 58.4% | ||
| Q4 24 | 73.5% | 55.5% | ||
| Q3 24 | 73.4% | 54.2% | ||
| Q2 24 | 72.5% | 52.0% |
| Q1 26 | — | 36.1% | ||
| Q4 25 | -8.5% | 19.9% | ||
| Q3 25 | 18.8% | 17.9% | ||
| Q2 25 | 15.1% | 16.8% | ||
| Q1 25 | 12.2% | 21.6% | ||
| Q4 24 | 14.5% | 16.9% | ||
| Q3 24 | 23.9% | 15.0% | ||
| Q2 24 | 20.3% | 11.8% |
| Q1 26 | — | 28.1% | ||
| Q4 25 | -32.2% | 13.2% | ||
| Q3 25 | 9.0% | 11.8% | ||
| Q2 25 | -14.6% | 10.6% | ||
| Q1 25 | -45.8% | 17.5% | ||
| Q4 24 | 10.0% | 10.8% | ||
| Q3 24 | -1.1% | 9.8% | ||
| Q2 24 | 1.6% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $0.95 | ||
| Q3 25 | $0.05 | $0.81 | ||
| Q2 25 | $-0.08 | $0.70 | ||
| Q1 25 | $-0.25 | $1.17 | ||
| Q4 24 | $0.07 | $0.74 | ||
| Q3 24 | $-0.01 | $0.66 | ||
| Q2 24 | $0.01 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.2M | $245.4M |
| Total DebtLower is stronger | $1.3B | $1.2B |
| Stockholders' EquityBook value | $552.5M | $796.3M |
| Total Assets | $3.2B | $2.4B |
| Debt / EquityLower = less leverage | 2.30× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | $90.2M | $363.4M | ||
| Q3 25 | $109.5M | $296.4M | ||
| Q2 25 | $110.3M | $292.9M | ||
| Q1 25 | $114.6M | $306.8M | ||
| Q4 24 | $121.2M | $320.8M | ||
| Q3 24 | $109.9M | $299.3M | ||
| Q2 24 | $121.7M | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.3B | $1.2B | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | $552.5M | $911.5M | ||
| Q3 25 | $634.6M | $849.2M | ||
| Q2 25 | $611.2M | $882.3M | ||
| Q1 25 | $593.0M | $820.8M | ||
| Q4 24 | $670.2M | $906.9M | ||
| Q3 24 | $683.4M | $878.9M | ||
| Q2 24 | $654.0M | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $3.2B | $2.5B | ||
| Q3 25 | $2.6B | $2.4B | ||
| Q2 25 | $2.6B | $2.5B | ||
| Q1 25 | $2.6B | $2.5B | ||
| Q4 24 | $2.6B | $2.5B | ||
| Q3 24 | $2.6B | $2.5B | ||
| Q2 24 | $2.6B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | 2.30× | 1.34× | ||
| Q3 25 | 2.11× | 1.44× | ||
| Q2 25 | 2.19× | 1.39× | ||
| Q1 25 | 2.21× | 1.49× | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 2.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.6M | $293.2M |
| Free Cash FlowOCF − Capex | $7.7M | $209.9M |
| FCF MarginFCF / Revenue | 2.7% | 60.6% |
| Capex IntensityCapex / Revenue | 4.6% | 9.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $20.6M | $93.6M | ||
| Q3 25 | $22.6M | $111.3M | ||
| Q2 25 | $6.5M | $17.4M | ||
| Q1 25 | $15.4M | $116.6M | ||
| Q4 24 | $39.7M | $43.8M | ||
| Q3 24 | $10.7M | $48.8M | ||
| Q2 24 | $46.4M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $7.7M | $87.2M | ||
| Q3 25 | $7.9M | $106.3M | ||
| Q2 25 | $-9.6M | $13.6M | ||
| Q1 25 | $-322.0K | $100.9M | ||
| Q4 24 | $24.6M | $35.2M | ||
| Q3 24 | $-1.8M | $39.4M | ||
| Q2 24 | $31.1M | $-33.1M |
| Q1 26 | — | 60.6% | ||
| Q4 25 | 2.7% | 25.7% | ||
| Q3 25 | 3.3% | 32.5% | ||
| Q2 25 | -4.1% | 4.2% | ||
| Q1 25 | -0.1% | 30.5% | ||
| Q4 24 | 9.9% | 10.1% | ||
| Q3 24 | -0.8% | 11.4% | ||
| Q2 24 | 13.6% | -9.8% |
| Q1 26 | — | 9.5% | ||
| Q4 25 | 4.6% | 1.9% | ||
| Q3 25 | 6.1% | 1.5% | ||
| Q2 25 | 6.9% | 1.2% | ||
| Q1 25 | 7.0% | 4.7% | ||
| Q4 24 | 6.1% | 2.5% | ||
| Q3 24 | 5.2% | 2.7% | ||
| Q2 24 | 6.7% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | — | 2.09× | ||
| Q3 25 | 1.05× | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | 1.61× | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | 12.59× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
